Kennedy RD - Search Results

1

Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage.

Johnson N, Cai D, Kennedy RD, Pathania S, Arora M, Li YC, D'Andrea AD, Parvin JD, Shapiro GI. Johnson N, et al. Among authors: kennedy rd. Mol Cell. 2009 Aug 14;35(3):327-39. doi: 10.1016/j.molcel.2009.06.036. Mol Cell. 2009. PMID: 19683496 Free PMC article.

2

Role played by BRCA1 in regulating the cellular response to stress.

Gilmore PM, Quinn JE, Mullan PB, Andrews HN, McCabe N, Carty M, Kennedy RD, Harkin DP. Gilmore PM, et al. Among authors: kennedy rd. Biochem Soc Trans. 2003 Feb;31(Pt 1):257-62. Biochem Soc Trans. 2003. PMID: 12546697 Review.

3

The role of BRCA1 in the cellular response to chemotherapy.

Kennedy RD, Quinn JE, Mullan PB, Johnston PG, Harkin DP. Kennedy RD, et al. J Natl Cancer Inst. 2004 Nov 17;96(22):1659-68. doi: 10.1093/jnci/djh312. J Natl Cancer Inst. 2004. PMID: 15547178 Review.

4

The Fanconi Anemia/BRCA pathway: new faces in the crowd.

Kennedy RD, D'Andrea AD. Kennedy RD, et al. Genes Dev. 2005 Dec 15;19(24):2925-40. doi: 10.1101/gad.1370505. Genes Dev. 2005. PMID: 16357213 Free article. Review.

5

Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway.

Chirnomas D, Taniguchi T, de la Vega M, Vaidya AP, Vasserman M, Hartman AR, Kennedy R, Foster R, Mahoney J, Seiden MV, D'Andrea AD. Chirnomas D, et al. Mol Cancer Ther. 2006 Apr;5(4):952-61. doi: 10.1158/1535-7163.MCT-05-0493. Mol Cancer Ther. 2006. PMID: 16648566

6

DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes.

Kennedy RD, D'Andrea AD. Kennedy RD, et al. J Clin Oncol. 2006 Aug 10;24(23):3799-808. doi: 10.1200/JCO.2005.05.4171. J Clin Oncol. 2006. PMID: 16896009 Review.

7

Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.

Wang X, Kennedy RD, Ray K, Stuckert P, Ellenberger T, D'Andrea AD. Wang X, et al. Among authors: kennedy rd. Mol Cell Biol. 2007 Apr;27(8):3098-108. doi: 10.1128/MCB.02357-06. Epub 2007 Feb 12. Mol Cell Biol. 2007. PMID: 17296736 Free PMC article.

8

Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.

Kennedy RD, Chen CC, Stuckert P, Archila EM, De la Vega MA, Moreau LA, Shimamura A, D'Andrea AD. Kennedy RD, et al. J Clin Invest. 2007 May;117(5):1440-9. doi: 10.1172/JCI31245. Epub 2007 Apr 12. J Clin Invest. 2007. PMID: 17431503 Free PMC article.

9

Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3.

Sidi S, Sanda T, Kennedy RD, Hagen AT, Jette CA, Hoffmans R, Pascual J, Imamura S, Kishi S, Amatruda JF, Kanki JP, Green DR, D'Andrea AA, Look AT. Sidi S, et al. Among authors: kennedy rd. Cell. 2008 May 30;133(5):864-77. doi: 10.1016/j.cell.2008.03.037. Cell. 2008. PMID: 18510930 Free PMC article.

10

CHK1 inhibition as a strategy for targeting Fanconi Anemia (FA) DNA repair pathway deficient tumors.

Chen CC, Kennedy RD, Sidi S, Look AT, D'Andrea A. Chen CC, et al. Among authors: kennedy rd. Mol Cancer. 2009 Apr 16;8:24. doi: 10.1186/1476-4598-8-24. Mol Cancer. 2009. PMID: 19371427 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters